Minimising the consequences of colorectal cancer treatment

Similar documents
NICaN workshop: Colorectal Cancer Follow-up

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

THE INTERNATIONAL CANCER BENCHMARKING PARTNERSHIP: GLOBAL LEARNING FROM OUR RESULTS Harpal Kumar, Chief Executive, Cancer Research UK UICC World

Colorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist

Early diagnosis and primary care UK perspec4ve David Weller University of Edinburgh

Britain against Cancer APPG Cancer Meeting 2009 Research & Technologies Workshop

UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals

Information Services Division NHS National Services Scotland

7/11/2011. The impact of cancer survival studies on health policy. NCI prevention budget falls. Cases Deaths Survivors

Information Services Division NHS National Services Scotland

Prevention of Bowel Cancer: which patients do I send for colonoscopy?

Diagnosing Cancer Earlier: reviewing the evidence for improving cancer survival 3 rd NAEDI Research Conference

LIST OF ABBREVIATIONS

Raising awareness of cancer symptoms. Amanda Boughey, Cancer Research UK September 2015

RCGP and Cancer Research UK Workshop

National Update: Living With and Beyond Cancer Implementing Strategic Priority 4 of the National Cancer Taskforce

Information Pack for GP s The implementation of the Faecal Immunochemical Test (FIT) across the South West

Information Services Division NHS National Services Scotland

Bowel cancer screening and prevention

A research briefing paper by Macmillan Cancer Support

RCGP and Cancer Research UK Workshop. Mercure Maidstone, Great Danes Hotel Maidstone ME17 1RE 19 th October 2017

Clinical Biochemistry Department City Hospital

Transforming Cancer Services for London

Colorectal Cancer Screening

Supplementary Online Content

Transforming cancer care: the bigger picture and what's next

Colonoscopy Quality Data

Bowel Cancer Screening

Module 2. Dr Anna Gavin Mr Conan Donnelly Dr Michael Donnelly Dr David Donnelly

Trends in Cancer Survival in Scotland

NCIN Conference Feedback 2015

Engaging Primary Care in bowel screening

Colorectal cancer screening

The general practice perspective on early diagnosis of blood cancers

Recognition and Referral of Suspected Cancer - NICE guidance and local initiatives

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE

Colorectal cancer screening in England

WHERE NEXT FOR CANCER SERVICES IN WALES? AN EVALUATION OF PRIORITIES TO IMPROVE PATIENT CARE

North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

EARLY DIAGNOSIS: CHALLENGES AND OPPORTUNITIES FOR GPs

Macmillan Publications

Early detection and screening for colorectal neoplasia

Epidemiological evidence linking food, nutrition, physical activity and prostate cancer risk: results from the Continuous Update Project

Razvan I. Arsenescu, MD Assistant Professor of Medicine Division of Digestive Diseases EARLY DETECTION OF COLORECTAL CANCER

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

Causation Issues. Delay in Diagnosis of Cancer Cases. Prof Pat Price Imperial College London

National Screening Programmes (Adult Population) Annual Report

EARLY DETECTION OF COLORECTAL CANCER. Epidemiology of CRC

PDF // POSITIVE COLON CANCER RESULTS

Colon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership

GI Screening/Surveillance in Lynch Syndrome

Prostate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC

Overview of 2009 Hong Kong Cancer Statistics

FACT SHEET 49. What is meant by a family history of bowel cancer? What is bowel cancer? What causes bowel cancer?

Northern Ireland Bowel Cancer Screening Programme. Pathways. Version 4 1 st October 2013

05/07/2018. Organisation. The English screening programme what is happening? Organisation. Bowel cancer screening in the UK is:

FIT for symptomatic patients. Facilitator name

Downloaded from:

Management of dyspepsia and of Helicobacter pylori infection

Bowel Cancer Screening Exploiting science brings better medicine

CANCER IN IRELAND with estimates for : ANNUAL REPORT OF THE NATIONAL CANCER REGISTRY

Prevention and management of cancer in primary care. Presentation + interactive discussion with DoHA 11am Wednesday November 7 th 2012

ENGAGING PRIMARY CARE IN BOWEL SCREENING

The Future of the Peer Review Programme

CANCER SCREENING. Er Chaozer Department of General Medicine, Tan Tock Seng Hospital

Clinical indications for positron emission tomography

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

Evaluation of the Bowel Cancer Awareness Pilot in SW and east of England, 31 st Jan to 18 th March 2011

Cancer risk in patients with kidney disease

Colon, or Colorectal, Cancer Information

8/26/17. Smoking Cessation and Cancer Prevention Jussuf T. Kaifi, MD, PhD, FACS Chief, Section for Thoracic Surgery. Cancer in the United States

FAMILIAL COLORECTAL CANCER. Lyn Schofield Manager Familial Cancer Registry

CANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012

Identifying and counting people living with treatable but not curable cancer

Prof Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

The primary care perspective Dr Richard Roope

Analysis of One- Year Cancer Survival Rates

Hereditary Breast and Ovarian Cancer (HBOC) Information for individuals and families

Referral Criteria for Direct Access Outpatient Colonoscopy or Computed Tomography Colonography

Cancer prevalence. Chapter 7

An Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018

Coversheet for Network Site Specific Group Agreed Documentation

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Bowel Screening Wales E-Bulletin October 2010

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Challenges for Colorectal Cancer Screening

EARLY DIAGNOSIS OF CANCER

Cost-effectiveness of an early awareness campaign for colorectal cancer

Cancer survival by stage at diagnosis in Wales,

Diagnostics for the early detection and prevention of colon cancer

Cancer Screenings and Early Diagnostics

Analysis of One- Year Cancer Survival Rates

Timing of surgery in FAP

For identification, support and follow up related to Familial Gastrointestinal Cancer conditions. South Island Cancer Nurses Network September 2013

Transcription:

Minimising the consequences of colorectal cancer treatment Muti Abulafi Consultant Colorectal Surgeon Croydon University Hospital Chair, Colorectal Pathway Group London Cancer Alliance

In two words Early diagnosis Bowel cancer is perhaps the only cancer that is preventable and 100% curable if detected early!!!

Why is colorectal cancer preventable Adenoma - Carcinoma Sequence Most colorectal cancers start as benign polyps called adenoma polyps. So if adenoma polyps are removed during endoscopic examinations then a cancer is prevented

Why is Colorectal Cancer curable if detected early Let us look at the 5 year survival of the various stages Stage 0-100% Stage I - 93 % Stage II - 71 % Stage III - 41 % Stage IV - 7% Therefore diagnosing a cancer early will lead to cure McDermott et al, Br J.Surg.1981;13846-849

Look at the survival rate of the UK vs Europe in the 90s

ICBP: 1 year relative survival. Coleman et al, Lancet 2011 90 85 AUS CAN SWE NOR DEN UK AUS SWE CAN 80 NOR DEN 75 UK 70 65 1995-99 2000-02 2005-07 Colorectal Cancer 1yr RS

Total around 10,000 pa Breast ~ 2000 Myeloma 250 Colorectal ~ 1700 Endometrial 250 Lung ~ 1300 Leukaemia 240 Kidney/Bladder ~ 990 Brain 225 Oesophagogastric ~ 950 Melanoma 190 Ovary ~ 500 Cervix 180 NHL/HD 370 Oral/Larynx 170 Pancreas 75 [NB Prostate has been excluded as survival gap is likely to be due to differences in PSA testing rates.] Data derived from Abdel-Rahman et al, BJC Supplement December 2009

What can we do to diagnose cancers early - therefore minimise the consequences of treatment 1. Improve Public health Education Better Primary and Secondary Prevention 2. Reduce Late presentation by patients to their GP Improve awareness of symptoms Minimise the barriers to accessing primary care 3. Supporting primary care to encourage early investigation and referral by addressing: GPs not recognising a problem as possible cancer? GPs not wanting to worry a patient when the likelihood of cancer is small? GPs having poor access to diagnostics? GPs being under pressure to limit referrals? 4. Improve quality of treatment, by addressing the following issues: Variable access to cancer surgery and variable surgical outcomes Inadequate Screening and Surveillance

What can we do to diagnose cancers early - therefore minimise the consequences of treatment Improve Public health Education: Better Primary and Secondary Prevention Primary Prevention Regular exercise Healthy body weight Dietary factors Folate Calcium Selenium Vitamin E Aspirin/NSAIDS Secondary Prevention Endoscopic or Surgical Polypectomy 93% colorectal cancers prevented National polyp study (USA) Prophylactic colectomy

What can we do to diagnose cancers early - therefore minimise the consequences of treatment Screening of colorectal cancer Perhaps the most effective way to achieve early diagnosis It diagnoses the condition before symptoms develop The cancers diagnosed by screening are mainly early stage with better outcomes Any polyps found will prevent development of cancers in years to come Currently uptake rate of screening programme is well below the national target of 60% - efforts need to improve this the more people we screen, the more cancers we detect. Currently the technology used to detect occult blood in the stools is old and there are new and sensitive tests used by other western countries. Moving to this test is likely to help us pick more cancers The age groups screened in England and wales starts at 60 to 75 years whereas in other western nations including Scotland it starts at 50 years.

Comparison of Dukes stage in screening vs two weeks detected cancers Courtney et al, Colorectal Dis. 2013; 15: 177-82

Screen detected colorectal cancers show improved cancer specific survival when compared with cancers diagnosed via the 2 week suspected colorectal cancer referral guidelines

Take Home Points Early Diagnosis is the Key to minimizing the consequences of cancer treatments in colorectal cancer Improving uptake of screening is most cost effective tool of early diagnosis